Advancing Public Health in China: Wecare Probiotics Unveils Phase III Strain Factory

The Healthy China initiative is showing promising results, with the nation's health metrics on the rise. Central to this progress is the launch of the Wecare Probiotics Phase III Strain Factory, a testament to the burgeoning domestic probiotics industry's vitality.

Probiotics are crucial for human health, maintaining microecological balance, boosting immunity, and helping prevent diseases. The new Wecare factory enhances the localization of probiotic strains, fostering industry growth and supporting the Healthy China strategy's goals.

As a leader in probiotics, Wecare is committed to delivering high-quality strains for diverse applications. The Phase III factory's inauguration meets growing market demands, aiming for an impressive 600-ton annual output of raw material probiotic powder, which constitutes over 90% of national production.

The Phase III factory, a major undertaking in Jiangsu Province, represents a 1.5 billion RMB investment. Significant funds are allocated to R&D and cutting-edge intelligent manufacturing lines. The facility boasts advanced equipment and automation, ensuring efficient, high-quality production.

Quality control is paramount at the Wecare factory. Comprehensive quality management systems monitor every stage from sourcing to delivery. State-of-the-art testing ensures all products meet stringent safety and efficacy standards.

The Phase III factory’s launch marks a milestone for Wecare Probiotics, significantly boosting capacity and technological prowess. This development strengthens the probiotics sector’s competitiveness and aligns with the Healthy China strategy, solidifying Wecare’s industry leadership and commitment to national health.